{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T20:19:08Z","timestamp":1776889148693,"version":"3.51.2"},"reference-count":15,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T00:00:00Z","timestamp":1452211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Neuropathic pain includes postherpetic neuralgia (PHN), painful diabetic neuropathy (PDN), and trigeminal neuralgia, and so on. Although various drugs have been tried to treat neuropathic pain, the effectiveness of the drugs sometimes may be limited for chronic intractable neuropathic pain, especially when they cannot be used at an adequate dose, due to undesirable severe side effects and the underlying disease itself. Botulinum toxin type A (BoNT-A) has been known for its analgesic effect in various pain conditions. Nevertheless, there are no data of nerve block in PHN and PDN. Here, we report two patients successfully treated with ultrasound-guided peripheral nerve block using BoNT-A for intractable PHN and PDN. One patient had PHN on the left upper extremity and the other patient had PDN on a lower extremity. Due to side effects of drugs, escalation of the drug dose could not be made. We injected 50 Botox units (BOTOX\u00ae, Allergan Inc., Irvine, CA, USA) into brachial plexus and lumbar plexus, respectively, under ultrasound. Their pain was significantly decreased for about 4\u20135 months. Ultrasound-guided nerve block with BoNT-A may be an effective analgesic modality in a chronic intractable neuropathic pain especially when conventional treatment failed to achieve adequate pain relief.<\/jats:p>","DOI":"10.3390\/toxins8010018","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T23:38:27Z","timestamp":1452296307000},"page":"18","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Ultrasound-Guided Nerve Block with Botulinum Toxin Type A for Intractable Neuropathic Pain"],"prefix":"10.3390","volume":"8","author":[{"given":"Young","family":"Moon","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul St. Mary\u2019s Hospital, 222 Banpo-Daero, Seoul 137-701, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul St. Mary\u2019s Hospital, 222 Banpo-Daero, Seoul 137-701, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hue","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul St. Mary\u2019s Hospital, 222 Banpo-Daero, Seoul 137-701, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul St. Mary\u2019s Hospital, 222 Banpo-Daero, Seoul 137-701, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul St. Mary\u2019s Hospital, 222 Banpo-Daero, Seoul 137-701, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2016,1,8]]},"reference":[{"key":"ref_1","unstructured":"Mersky, H., and Bogduk, N. (1994). Classification of Chronic Pain, IASP Press."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3344\/kjp.2010.23.2.99","article-title":"Pharmacologic management of chronic pain","volume":"23","author":"Park","year":"2010","journal-title":"Korean J. Pain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1212\/01.wnl.0000259085.61898.9e","article-title":"The impact of neuropathic pain on health-related quality of life: Review and implications","volume":"68","author":"Jensen","year":"2007","journal-title":"Neurology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3344\/kjp.2010.23.1.65","article-title":"Ganglion impar block with botulinum toxin type A for chronic perineal pain -a case report","volume":"23","author":"Lim","year":"2010","journal-title":"Korean J. Pain"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3344\/kjp.2015.28.3.177","article-title":"Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment","volume":"28","author":"Jeon","year":"2015","journal-title":"Korean J. Pain"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/dmrr.1225","article-title":"Painful diabetic peripheral neuropathy: Consensus recommendations on diagnosis, assessment and management","volume":"27","author":"Tesfaye","year":"2011","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2217\/pmt.13.75","article-title":"Botulinum toxin for neuropathic pain and spasticity: An overview","volume":"4","author":"Brown","year":"2014","journal-title":"Pain Manag."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1533-2500.2007.00150.x","article-title":"Botulinum toxin occipital nerve block for the treatment of severe occipital neuralgia: A case series","volume":"7","author":"Kapural","year":"2007","journal-title":"Pain Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/j.1526-4610.2008.01089.x","article-title":"Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: A pilot study","volume":"48","author":"Taylor","year":"2008","journal-title":"Headache"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","article-title":"Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial","volume":"72","author":"Yuan","year":"2009","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/AJP.0b013e318255c132","article-title":"OnabotulinumtoxinA improves tactile and mechanical pain perception in painful diabetic polyneuropathy","volume":"29","author":"Chen","year":"2013","journal-title":"Clin. J. Pain"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1526-4637.2010.01003.x","article-title":"Subcutaneous injection of botulinum toxin A is beneficial in postherpetic neuralgia","volume":"11","author":"Xiao","year":"2010","journal-title":"Pain Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2004.02.043","article-title":"Involvement of peripherally released substance P and calcitonin gene-related peptide in mediating mechanical hyperalgesia in a traumatic neuropathy model of the rat","volume":"360","author":"Jang","year":"2004","journal-title":"Neurosci. Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuroscience.2004.06.040","article-title":"Peripheral glutamate receptors contribute to mechanical hyperalgesia in a neuropathic pain model of the rat","volume":"128","author":"Jang","year":"2004","journal-title":"Neuroscience"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/0333102414527648","article-title":"Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains","volume":"34","author":"Burstein","year":"2014","journal-title":"Cephalalgia"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/8\/1\/18\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:17:28Z","timestamp":1760210248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/8\/1\/18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,8]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1]]}},"alternative-id":["toxins8010018"],"URL":"https:\/\/doi.org\/10.3390\/toxins8010018","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,8]]}}}